These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Antiandrogenic properties of spironolactone. Clinical trial in the management of female hirsutism. Messina M; Manieri C; Biffignandi P; Massucchetti C; Novi RF; Molinatti GM J Endocrinol Invest; 1983 Feb; 6(1):23-7. PubMed ID: 6404979 [TBL] [Abstract][Full Text] [Related]
8. Side-effects of spironolactone therapy in the hirsute woman. Helfer EL; Miller JL; Rose LI J Clin Endocrinol Metab; 1988 Jan; 66(1):208-11. PubMed ID: 3335604 [TBL] [Abstract][Full Text] [Related]
9. Low-dose spironolactone in the treatment of female hirsutism. Ylöstalo P; Heikkinen J; Kauppila A; Pakarinen A; Järvinen PA Int J Fertil; 1987; 32(1):41-5. PubMed ID: 2880814 [TBL] [Abstract][Full Text] [Related]
10. A comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism. Keleştimur F; Everest H; Unlühizarci K; Bayram F; Sahin Y Eur J Endocrinol; 2004 Mar; 150(3):351-4. PubMed ID: 15012621 [TBL] [Abstract][Full Text] [Related]
11. [The treatment of hirsutism in adolescent girls with spironolactone]. Malinova M Akush Ginekol (Sofiia); 1999; 38(4):28-30. PubMed ID: 10726349 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism. Erenus M; Gürbüz O; Durmuşoğlu F; Demirçay Z; Pekin S Fertil Steril; 1994 Apr; 61(4):613-6. PubMed ID: 8150100 [TBL] [Abstract][Full Text] [Related]
13. Spironolactone in the treatment of idiopathic hirsutism and the polycystic ovary syndrome. Evans DJ; Burke CW J R Soc Med; 1986 Aug; 79(8):451-3. PubMed ID: 3761287 [TBL] [Abstract][Full Text] [Related]
14. Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism. Erenus M; Yücelten D; Gürbüz O; Durmuşoğlu F; Pekin S Fertil Steril; 1996 Aug; 66(2):216-9. PubMed ID: 8690104 [TBL] [Abstract][Full Text] [Related]
15. Spironolactone as a single agent for long-term therapy of hirsute patients. Spritzer PM; Lisboa KO; Mattiello S; Lhullier F Clin Endocrinol (Oxf); 2000 May; 52(5):587-94. PubMed ID: 10792338 [TBL] [Abstract][Full Text] [Related]
16. Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone. Wild RA; Demers LM; Applebaum-Bowden D; Lenker R Contraception; 1991 Aug; 44(2):113-24. PubMed ID: 1893706 [TBL] [Abstract][Full Text] [Related]
17. [Spironolactone in idiopathic hirsutism, clinical and biological evaluation of treatment]. Abramovici Y; Guillet F; Matte R; Chaieb L; Belanger R Ann Endocrinol (Paris); 1983; 44(6):393-6. PubMed ID: 6430208 [TBL] [Abstract][Full Text] [Related]
18. Predictors of clinical response in hirsute women treated with spironolactone. Crosby PD; Rittmaster RS Fertil Steril; 1991 Jun; 55(6):1076-81. PubMed ID: 1828043 [TBL] [Abstract][Full Text] [Related]
19. Dexamethasone and spironolactone in the treatment of non-tumorous hyperandrogenism. Prezelj J; Kocijancic A; Andolsek L Gynecol Endocrinol; 1989 Dec; 3(4):281-8. PubMed ID: 2516705 [TBL] [Abstract][Full Text] [Related]
20. [Cyproterone acetate and spironolactone compared in the therapy of female hirsutism]. Suraci C; Costa C; De Pedrini P Clin Ter; 1983 Mar; 104(6):463-7. PubMed ID: 6221860 [No Abstract] [Full Text] [Related] [Next] [New Search]